Breaking News
Get 55% Off 0
🔺 What to do when markets are at an all-time high? Find smart bargains, like these.
See Undervalued Shares
Close

Pfizer Inc (PFE_KZ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
25.85 -0.02    -0.08%
07:02:00 - Delayed Data. Currency in USD
  • Volume: 7
  • Bid/Ask: 25.84 / 26.32
  • Day's Range: 25.50 - 26.40
Type:  Equity
Market:  Kazakhstan
ISIN:  US7170811035 
Pfizer 25.85 -0.02 -0.08%

Pfizer Company Profile

 
Read the Pfizer company profile to learn more about the business and the management team. View Pfizer facts about how many employees Pfizer has, PFE company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

88000

Equity Type

ORD

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Contact Information

Address 66 Hudson Boulevard East
New York, 10001-2192
United States
Phone 212 733 2323
Fax -

Top Executives

Name Age Since Title
Charles T. Hagel 77 - Member of Emerging Markets Advisory Board
Shantanu Narayen 59 2013 Lead Independent Director
Albert Bourla 61 2016 Chairman of the Board & CEO
Joseph J. Echevarria 66 2015 Independent Director
Helen H. Hobbs 71 2011 Independent Director
Suzanne M. Nora Johnson 66 2007 Independent Director
James C. Smith 63 2014 Independent Director
Daniel R. Littman 70 2018 Independent Director
Susan Desmond-Hellmann 66 2020 Independent Director
Scott Gottlieb 50 2019 Independent Director
James Robert B. Quincey 58 2020 Independent Director
Ronald E. Blaylock 63 2017 Independent Director
Susan J. Hockfield 71 2020 Independent Director
Cyrus Russi Jal Taraporevala 57 - Director
Mortimer Joseph Buckley - 2024 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Pfizer (PFE) Price Discussion

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ioannis Sarpaki
Ioannis Sarpaki Nov 05, 2024 15:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Poor Dr Bourla!
sohail qulla
sohail qulla Feb 29, 2024 22:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can anybody guide please as I bought it at 37 and still holding. What's prospects in near future?
YB Z
YB Z Feb 29, 2024 22:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy some now at bottom
Tharmabalan Tharmendhra
Tharmabalan Tharmendhra Feb 29, 2024 22:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Best investing decision is buy good quality stock at fair value especially on the dividend yield will off set the loses on initially you purchased and continued to reinvesting them if you belive in the fundamental on the business.these stock got history for decades and its on 52wk low ,if I were you I'll average dollar cost until become 0 cist and with commanding dividend. if you can't hold for at least few years for any stocks my humble requesting you never put anymore money into it.good luck
Mark Southgate
Mark Southgate Feb 29, 2024 22:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
As of March 2023, the average analyst one year ahead price target is $32.22 for what it's worth - average is from 27 analysts and 44% of those rate it a buy and 56% rate it a hold. 6% dividend yield, so you 'get paid to wait'...
Mark Southgate
Mark Southgate Feb 29, 2024 22:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Oops, that info is as of March 2024, sorry about the typo!
Anon Anon
Anon Anon Jan 03, 2024 4:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think we've seen the bottom.
Federico Bonezzi
Federico Bonezzi Jan 03, 2024 4:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It’s gonna still go down another 10-15% and have a very slow recovery. Sadly, I have to admit, this was a very poor stock choice for me
Ioannis Sarpaki
Ioannis Sarpaki Jan 03, 2024 4:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Poor pfizer!
Anon Anon
Anon Anon Oct 23, 2023 18:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought at 31 today. Avg around 32
mohamed sulibi
mohamed sulibi Sep 06, 2023 19:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
over sold .. it does not deserve it best at starting 35
Anon Anon
Anon Anon May 24, 2023 5:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Folks who disliked me back in Oct. I got back in around 37
Rafal Kramek
Rafal Kramek May 22, 2023 20:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is the uptrend started now?
mohamed sulibi
mohamed sulibi May 19, 2023 5:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
my avg 38 $ .. still holding
Darren Mason
Darren Mason Feb 03, 2023 5:11
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thailand Princess & Pfizer....
Rickard Costan
Rickard Costan Jan 27, 2023 19:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Project Veritas...
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email